MENU
BEAM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Beam Therapeutics (BEAM) Ownership - Who owns Beam Therapeutics?
Profile
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.4B
P/E Ratio
N/A
Total Cash
925.76M
Projected Growth
N/A
Total Debt
162.07M
Revenue
349.64M
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
11.18
Total Debt/Equity
N/A
Revenue/Share
4.27 USD as % of share price
Fundamentals
BEAM
Capitalization
2.41B
P/E Ratio
N/A
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash
926M
Total Cash/Share
11.18
Total Debt
162M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.27%
Revenue
350M
ROE
N/A
Book Value
791M
P/B Ratio
3.04
Cash Flow
N/A
Earnings
-1.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
826K
Current Ratio
5.69
Current Revenue Per Employee
38152.41
Dividends Per Share - Security
N/A
EBITDA
-160.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.67
Shares Held By Institutions
4.49B
Shares Outstanding - Current
82.8M
Total Liabilities
380M
Total Volume MTD
N/A
Value
N/A
Gain YTD
6.576
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com